Try it
Pharmacology · Cardiovascular: pulmonary hypertension drugs
Sample itemBosentan, used in pulmonary arterial hypertension, acts through which mechanism?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Endothelin receptor antagonism
Bosentan blocks endothelin ETA and ETB receptors, reducing pulmonary vasoconstriction, and it is hepatotoxic and teratogenic. Sildenafil inhibits PDE5 and epoprostenol is a prostacyclin.
Option by option
A. Soluble guanylate cyclase stimulation
Riociguat stimulates soluble guanylate cyclase.
B. Endothelin receptor antagonism (correct)
Correct. Bosentan is an endothelin antagonist.
C. Prostacyclin analogue action
Prostacyclin analogues include epoprostenol and treprostinil.
D. Phosphodiesterase 5 inhibition
PDE5 inhibition is the action of sildenafil.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?